The humanoid industry spent two years raising private money at a record pace. In the middle of July 2026 it started reaching for the public kind. Unitree Robotics won approval for a roughly $618 million IPO on Shanghai's STAR Market; Agility Robotics agreed to go public through a $2.5 billion SPAC merger; and LimX Dynamics closed nearly $200 million in pre-IPO financing on July 15. CNBC reported the same week that, among Chinese humanoid startups, "listing is a must." Three deals in three formats, one direction of travel.

Venture capital funds the question "does the robot work?" Public markets fund the question "does the business?" The sector just moved from the first to the second. — EW analysis

Why the exit door is opening now

The pull is manufacturing. Building humanoids at the volumes these companies now promise — thousands of units a month — is a capital-hungry, low-margin industrial slog, and it needs deeper, more liquid funding than even the largest private rounds provide. A listing supplies that, plus a currency (public stock) for acquisitions and for retaining engineers. It also gives the venture and strategic investors who wrote the early cheques a way out.

Geography shapes the format. In China, a receptive STAR Market and explicit state support make a domestic listing the natural next step, which is why Unitree's approval drew such attention and why LimX is labeling its round "pre-IPO." In the U.S., where a traditional IPO for a pre-profit hardware company is a harder sell, Agility chose a SPAC — faster to close, but a structure that has burned public investors before. Notably, Agility's leadership has paired the listing with candor rather than hype, declining to promise a robot in every home; that framing is itself a signal that going public forces a more disciplined story.

The new scoreboard

Listing changes what counts. Private valuations rest on narrative and the last investor's mark; public ones rest on filings. Once these companies trade, the market will price them on disclosed revenue, gross margin, order backlog and units actually deployed and paid for — the metrics demo reels are designed to skip. That discipline cuts both ways. It could reward the makers with real industrial traction and expose the ones whose valuations ran ahead of their shipments, and the first few quarters of humanoid earnings reports will do more to sort the field than any product launch.

Key Facts

  • Unitree Robotics: approved for a ~$618M IPO on Shanghai's STAR Market
  • Agility Robotics: going public via a $2.5B SPAC merger
  • LimX Dynamics: nearly $200M pre-IPO round closed July 15, 2026
  • CNBC (July 13): Chinese humanoid startups broadly rushing to list
  • Driver: capital for manufacturing scale-up plus a path to exit for early backers

Why it matters

An IPO wave is a maturity signal and a stress test at once. It says investors believe humanoids are a real industry worth public-market capital; it also means the sector is about to be graded in public, on numbers, every quarter. The companies that welcome that scrutiny are telling you something — and so are the ones that rush to list before their order books can survive it.

Frequently Asked

Which humanoid companies are going public?

Unitree (a ~$618M Shanghai STAR Market IPO), Agility Robotics (a $2.5B SPAC merger) and LimX Dynamics (a ~$200M pre-IPO round), all within weeks in mid-2026, with CNBC reporting a broader rush among Chinese startups.

Why list now?

To fund capital-intensive manufacturing scale-up with deeper, more liquid capital, and to give early investors an exit. China's STAR Market and state support make domestic listings viable.

What changes once they're public?

Pricing shifts from private narrative to disclosed revenue, margins, backlog and deployed units — proving the business, not just the robot.